ONYX-015, an adenovirus made conditionally replicative by E1B-55k gene deletion [8,9], is a potential candidate for treatment of p53-deficient cancers, with minimum replication in cells with a functional p53 pathway [10]. The gene discussed is TP53; the disease is cancer.